These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 628779)

  • 21. Design and simulation of a neutron facility.
    Studenski MT; Kearfott KJ
    Health Phys; 2007 Feb; 92(2 Suppl):S37-44. PubMed ID: 17228186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New radiation protection standards for medical electron accelerators].
    Berger H
    Strahlentherapie; 1978 Apr; 154(4):287. PubMed ID: 644603
    [No Abstract]   [Full Text] [Related]  

  • 23. A prediction of accelerator-produced activation products.
    Culp T
    Health Phys; 2007 Feb; 92(2 Suppl):S57-65. PubMed ID: 17228190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depth distribution of residual radioactivities in the concrete wall of an electron linac facility.
    Urabe I; Kobayashi K; Fujita Y; Tsujimoto T; Jin GC
    Health Phys; 1991 Apr; 60(4):587-91. PubMed ID: 2001958
    [No Abstract]   [Full Text] [Related]  

  • 25. Radionuclide production aspects of a CS-30 cyclotron.
    Beaver JE; Bolomey L; Nash D; Fernandez-Rubio F
    Prog Nucl Med; 1978; 4():28-33. PubMed ID: 628780
    [No Abstract]   [Full Text] [Related]  

  • 26. The Spallation Neutron Source (SNS) project: a fertile ground for radiation protection and shielding challenges.
    Gallmeier FX; Ferguson PD; Popova II; Iverson EB
    Radiat Prot Dosimetry; 2005; 115(1-4):23-32. PubMed ID: 16381678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Intensity Proton Accelerator Project in Japan (J-PARC).
    Tanaka S
    Radiat Prot Dosimetry; 2005; 115(1-4):33-43. PubMed ID: 16381679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new design for truly self-shielding baby-cyclotrons for production of positron emitters.
    Abs M; Bol JL; Chevalier A; Conard E; Jongen Y; Ladeuze M; Lannoye G; Laycock SC; Le Docte T; Morelle JL
    Acta Radiol Suppl; 1991; 376():74-5. PubMed ID: 1666791
    [No Abstract]   [Full Text] [Related]  

  • 29. Design of radiation shielding for the proton therapy facility at the National Cancer Center in Korea.
    Kim JW; Kwon JW; Lee J
    Radiat Prot Dosimetry; 2005; 115(1-4):271-5. PubMed ID: 16381727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The production and use of cyclotron isotopes in Turku, Finnland.
    Brenner M; Heselius SJ; Solin O
    Radiobiol Radiother (Berl); 1983; 24(4):563-8. PubMed ID: 6647805
    [No Abstract]   [Full Text] [Related]  

  • 31. Analysis of a shield design for a DT neutron generator test facility.
    Chichester DL; Pierce GD
    Appl Radiat Isot; 2007 Oct; 65(10):1125-33. PubMed ID: 17659876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Utilization of instruments and equipments for radiation protection in the radioisotope laboratories and radiation areas (III) (author's transl)].
    Ikeda N; Kawanishi M; Kurihara N; Sato O; Tsurufuji S; Nakano E; Nakamura A; Nakamura Y; Niki E; Fujita M; Morikawa N
    Radioisotopes; 1981 Nov; 30(11):628-37. PubMed ID: 7335903
    [No Abstract]   [Full Text] [Related]  

  • 33. Comments on the transverse shielding of proton accelerators.
    Tesch K
    Health Phys; 1983 Jan; 44(1):79-82. PubMed ID: 6298148
    [No Abstract]   [Full Text] [Related]  

  • 34. [Measurement of the air activation caused by the use of medical accelerators].
    Jensen JM
    Strahlentherapie; 1982 Jul; 158(7):427-31. PubMed ID: 7135439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement in beam current performance of the biomedical cyclotron at Memorial Sloan-Kettering Cancer Center.
    Kuo TY; Laughlin JS
    Prog Nucl Med; 1978; 4():6-15. PubMed ID: 628784
    [No Abstract]   [Full Text] [Related]  

  • 36. Proceedings from the tenth course on accelerator radiation protection. International School of Radiation Damage and Protection. Erice, Sicily. October 2-9, 2001.
    Radiat Prot Dosimetry; 2001; 96(4):293-457. PubMed ID: 12182125
    [No Abstract]   [Full Text] [Related]  

  • 37. [Current topics in radiopharmaceuticals in Japan. (III) Cyclotron-radiopharmaceuticals and clinical applications].
    Ido T
    Radioisotopes; 1984 Feb; 33(2):109-14. PubMed ID: 6610890
    [No Abstract]   [Full Text] [Related]  

  • 38. [Possibilities of medico-biological use of the 1st Hungarian cyclotron].
    Uray I
    Orv Hetil; 1982 Dec; 123(49):3021-3. PubMed ID: 7155574
    [No Abstract]   [Full Text] [Related]  

  • 39. The medical case for an Australian national cyclotron facility.
    Morris JG; Boyd RE; Smith RS; Hardy CJ; Towson JE; Bautovich GJ; Hutton BF
    Med J Aust; 1985 Apr; 142(8):454-7. PubMed ID: 3872404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation protection problems at a synchrotron radiation facility.
    Esposito A; Pelliccioni M
    Health Phys; 1982 May; 42(5):703-11. PubMed ID: 7085309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.